1. Potencjalne możliwości wykorzystania berberyny w przeciwdziałaniu insulinooporności i w cukrzycy typu 2
   Michalina Mróz et al, 2021, Postępy Higieny i Medycyny Doświadczalnej CrossRef
2. Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo
   Jian Chen et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
3. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases
   Tarun Belwal et al, 2020, Frontiers in Pharmacology CrossRef
4. Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
   Ya-Fei Liu et al, 2023, Frontiers in Pharmacology CrossRef
5. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota
   Ying Wang et al, 2021, Frontiers in Endocrinology CrossRef
6. The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis
   Mohammad Zamani et al, 2022, Frontiers in Nutrition CrossRef
7. Effects of Berberis asiatica, Withania somnifera, and Their Combination on Body Weight in Streptozotocin-Nicotinamide-Induced Type 2 Diabetes in Wistar Rats
   Devkumar D Tiwari et al, 2024, Cureus CrossRef
8. Targeting insulin resistance: myricetin and isorhamnetin from Hardwickia binata , and luteolin from Hedysarum alpinum enhance glucose uptake and AMPK signaling in HepG2 cells
   Shiva Shankar Reddy Nimmala et al, 2024, Natural Product Research CrossRef
9. The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis
   Richard Y. Cao et al, 2021, Frontiers in Pharmacology CrossRef
10. Association of higher plasma leptin levels with HOMA-IR index, high sensitivity C-reactive protein and glycolipid metabolism in patients with chronic schizophrenia: A multi-center cross-sectional study
    Zhiwei Liu et al, 2022, Frontiers in Psychiatry CrossRef
11. Metabolic Syndrome-Related Kidney Injury: A Review and Update
    Lirong Lin et al, 2022, Frontiers in Endocrinology CrossRef
12. Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line
    Bharti Mangla et al, 2024, Nanomedicine CrossRef
13. Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated
    Serafino Fazio et al, 2024, Frontiers in Cardiovascular Medicine CrossRef
14. Alkaloids as Promising Agents for the Management of Insulin Resistance: A Review
    Ayoub Amssayef et al, 2023, Current Pharmaceutical Design CrossRef